Edap Tms Osake

Edap Tms EBITDA

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Edap Tms (EDAP) 10.8.2026 päivämäärällä on −28,47 M EUR. Edellisenä vuonna EBITDA (Tulos ennen korkoja, veroja ja poistoja) oli −23,38 M EUR — muutos 21,78 % (matalampi).

EBITDA

−28,47 MEUR

YoY

21,78%

Viimeksi päivitetty:

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Edap Tms on 2026 −28,47 M EUR. EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Edap Tms oli 2025 −23,38 M EUR. Se laskee 21,78% matalampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Edap Tms Osakeanalyysi

Mitä Edap Tms tekee? Edap Tms SA is a French company specialized in the development and marketing of medical devices. The company was founded in 1979 and has its headquarters in Vaulx-en-Velin, France. With over 300 employees, Edap Tms SA operates worldwide and has branches in the USA, Asia, and Europe. The company's business model is based on the development of non-invasive medical devices, particularly HIFU (High-Intensity Focused Ultrasound) devices. With its technology, the company has developed a revolutionary new procedure for tumor treatment that can replace traditional radiation therapy. HIFU offers a gentler and more precise alternative for tumor treatment without damaging the surrounding tissue. Edap Tms SA offers its products and services in four main business areas: 1. HIFU systems for the treatment of prostate cancer: Edap Tms SA has developed a HIFU system capable of treating prostate cancer without invasive procedures. The system uses a special ultrasound probe inserted into the rectum to locate the tumor and direct targeted sound waves at the tumor, destroying cancer cells. 2. HIFU systems for the treatment of kidney cancer: Edap Tms SA has also developed a HIFU system capable of treating kidney cancer tumors. It works similarly to the prostate cancer system, effectively destroying the tumor through targeted sound waves. 3. Mobile HIFU devices: Edap Tms SA has developed mobile HIFU devices suitable for use in hospitals and clinics. These devices can be quickly and easily transported from room to room, allowing medical professionals to perform HIFU treatments without the need for additional equipment. 4. Bladder cancer treatment technology: Edap Tms SA has also developed technology used in the treatment of bladder cancer. The system also utilizes HIFU technology to destroy tumor cells, but it is introduced through the urethra and focuses on the tumor in the bladder. Edap Tms SA is a global leader in the development and marketing of HIFU systems. The company aims to improve cancer treatment and provide patients with a more effective and gentler alternative to traditional radiation therapy. With a wide range of products suitable for various types of cancer and a strong presence in the USA, Europe, and Asia, Edap Tms SA is a highly regarded brand in the medical device field. Overall, Edap Tms SA is a company with a rich history that focuses on innovative technologies and continuously strives to improve the lives of cancer patients. With its HIFU portfolio and strong market presence, the company is on track to achieve its goals and solidify its position as one of the leading providers of medical devices worldwide. Edap Tms on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Edap Tms osakkeesta

Yhtiön Edap Tms EBITDA (Tulos ennen korkoja, veroja ja poistoja) on −28,47 M EUR vuonna 2026.

EBITDA (Tulos ennen korkoja, veroja ja poistoja) yhtiöstä Edap Tms muuttui arvosta −23,38 M EUR arvoon −28,47 M EUR, mikä edustaa 21,78 % muutosta. Arvo on matalampi kuin edellisenä vuonna.

Eurpoolissa voit löytää EBITDA (Tulos ennen korkoja, veroja ja poistoja) Edap Tms:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

EBITDA mittaa operatiivista suorituskykyä ennen rahoitusrakenteen, veroympäristön ja muiden kuin käteispoisto-osuuksien vaikutusta.

EBITDA = EBIT + Poistot

EBITDA (Tulos ennen korkoja, veroja ja poistoja):n EUR on sijoittajille tärkeä tekijä. Muutokset tässä tunnusluvussa voivat signaloida parantuvia tai heikentyneitä perustekijöitä, mikä vaikuttaa suoraan osakekurssiin. Eulerpoolissa voit seurata EBITDA (Tulos ennen korkoja, veroja ja poistoja):n Edap Tms historiallisesti ja reaaliajassa.

Access this data via the Eulerpool API

Tuloslaskelma — Edap Tms

Kaikki tunnusluvut — Edap Tms